IP Library Granted Patent US 11,085,077
Granted Patent B2
US 11,085,077 · App. 16/162,848 · Granted Aug 10, 2021

Analysis of a polynucleotide via a nanopore system

Inventors: Stuart William Reid (Oxford, GB); Gavin Harper (Oxford, GB)
Assignee: Oxford Nanopore Technologies Ltd.
C12Q1/6869C12Q1/6806
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,085,077
App. No.
16/162,848
Granted
Aug 10, 2021
Kind
B2
Abstract

A target polynucleotide is expanded. In respect of each nucleotide in the target polynucleotide, the target polynucleotide comprises clock nucleotides and at least one signal nucleotide in a predetermined order. The clock nucleotides have a predetermined sequence common to each nucleotide in the target polynucleotide. The at least one signal nucleotide is characteristic of the identity of the respective nucleotide in the target polynucleotide. During translocation of the expanded polynucleotide through a nanopore, electrical measurements dependent on the polynucleotide within the pore are made, to derive an analysis signal. Clock signals derived from the clock nucleotides are identified. Relative to the positions of the identified clock signals, nucleotide signals derived from the least one signal nucleotide are derived to analyse the target polynucleotide. The predetermined sequence of the clock nucleotides comprises a restriction site for a restriction enzyme and at least one further nucleotide that extends the predetermined sequence.

Claims (12)

1. A method of expanding a target polynucleotide that comprises at each nucleotide position a member of a set of different nucleotides, the method comprising:

expanding, by a technique employing a restriction enzyme, each member of the set of different nucleotides in the target polynucleotide in order of its nucleotide position into an ordinally corresponding expanded unit to form an expanded polynucleotide, wherein each expanded unit comprises:

i) a clock nucleotide sequence, the clock nucleotide sequence being common among expanded units of the expanded polynucleotide; and

ii) at least one signal nucleotide, the at least one signal nucleotide being indicative of the member of the set of different nucleotides at the particular nucleotide position;

wherein the clock nucleotide sequence comprises:

1) a plurality of nucleotides that is a restriction site for the restriction enzyme and

2) at least one further nucleotide.

2. A method according to claim 1 , wherein the at least one signal nucleotide consists of a single signal nucleotide.

3. A method according to claim 2 , wherein the single signal nucleotide has the same identity as the member of the set of different nucleotides at the particular nucleotide position.

4. A method according to claim 1 , wherein the at least one signal nucleotide consists of a signal nucleotide sequence of plural signal nucleotides, wherein the signal nucleotide sequence is indicative of the member of the set of different nucleotides at the particular nucleotide position.

5. A method according to claim 4 , wherein one of the plural signal nucleotides has the same identity as the member of the set of different nucleotides at the particular nucleotide position.

6. A method according to claim 4 or 5 , wherein the clock nucleotide sequence and the signal nucleotide sequence are in a predetermined order in which the signal nucleotide sequence is contiguous.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2019
From: REID, STUART WILLIAM; HARPER, GAVIN
To: OXFORD NANOPORE TECHNOLOGIES LTD.
Reel/Frame 048042/0096 →
Priority Claims (1)
GB 1222928 · Dec 19, 2012 · national
Continuity (2)
Continuation 14653656
Related Publication 20190203286A1 · Jul 4, 2019
Cited By (5)
US 12,216,110 US 12,351,867 US 12,486,534 US 12,545,955 US 12,545,956